Loading
NASDAQFinancial ServicesFinancial - Conglomerates
Latest quote
$10.165
−$0.005 · -0.05%
Drugs Made In America Acquisition II Corp. currently lacks significant business operations. Its core objective is to execute a business combination, which may take various forms such as a merger, an acquisition of assets or shares, a recapitalization, or a reorganization, with one or more other entities. The company was founded in 2024 and maintains its principal office in Fort Lauderdale, Florida.
Previous close
$10.165
−$0.005 · -0.05%
After-hours
$10.16
−$0.005 · -0.05%
Sep 8, 4:00 PM ET
Regular session · ET · Market data may be delayed.
Drugs Made In America Acquisition II Corp. currently lacks significant business operations. Its core objective is to execute a business combination, which may take various forms such as a merger, an acquisition of assets or shares, a recapitalization, or a reorganization, with one or more other entities. The company was founded in 2024 and maintains its principal office in Fort Lauderdale, Florida.
Day range
Current $10.165
52-week range
Current $10.165
Regular session · ET · Market data may be delayed.
GoAI Score
Buy
Valuation
85
Deep Value
Sentiment
55
Mixed
Risk
8
Low Risk
Momentum
40
Weakening
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Drugs Made In America Acquisition II Corp. currently lacks significant business operations. Its core objective is to execute a business combination, which may take various forms such as a merger, an acquisition of assets or shares, a recapitalization, or a reorganization, with one or more other entities. The company was founded in 2024 and maintains its principal office in Fort Lauderdale, Florida.
Day range
Current $10.165
52-week range
Current $10.165
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 |
|---|---|---|
| Selling, general, and administrative | 488.39K USD | 151.72K USD |
| Operating expenses | 1.3M USD | 151.72K USD |
| Interest income | 4.93M USD | — |
| Operating income | −1.3M USD | −151.72K USD |
| Net income | 4.19M USD | −151.72K USD |
Company facts updated Sep 9, 2026.
Reported history and fiscal-year consensus
Reported history and fiscal-year consensus
Funds reporting this stock among their holdings, ordered by reported position size.
AI-generated and delayed market data for informational and educational purposes only. Not investment advice.
